NFE2L2 and Alzheimer disease: The reduced activity of NRF2 that we observed in AD patients as well as in our mouse model is consistent with the reduced expression of the NRF2 target glutathione S-transferase A4 (GSTA4) in lesional skin of AD patients (Ma et al., 2024).